Haemonetics Corporation (HAE)

Inventory turnover

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cost of revenue	US$ in thousands	611,866	617,507	553,563	487,694	472,625
Inventory	US$ in thousands	365,141	317,202	259,379	293,027	322,614
Inventory turnover		1.68	1.95	2.13	1.66	1.46

March 31, 2025 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $611,866K ÷ $365,141K
= 1.68

Inventory turnover for Haemonetics Corporation has shown a fluctuating trend over the past five years. In March 2021, the inventory turnover stood at 1.46, indicating that the company converted its inventory into sales 1.46 times during that period.

There was a slight improvement in inventory turnover in March 2022, reaching 1.66, suggesting a slightly more efficient management of inventory. Subsequently, in March 2023, the inventory turnover increased significantly to 2.13, reflecting a notable enhancement in the company's ability to sell through its inventory quickly.

However, in March 2024, the inventory turnover slightly decreased to 1.95, indicating a slight decline in the efficiency of inventory management compared to the previous year. Unfortunately, the data for March 2025 indicates a missing value, making it difficult to assess the most recent performance.

Overall, Haemonetics Corporation's inventory turnover has shown variability, with improvements in certain years and slight declines in others, reflecting the company's ability to manage its inventory effectively and efficiently convert it into sales. Insufficient information for 2025 limits a comprehensive analysis for the latest period. Further insights would be necessary to determine the current state of the company's inventory turnover efficiency.